NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide
about
sameAs
Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosaAspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammationPharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disordersCitric acid effects on brain and liver oxidative stress in lipopolysaccharide-treated mice.Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties.Selective inducible nitric oxide synthase inhibition attenuates organ dysfunction and elevated endothelin levels in LPS-induced DIC model rats.Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirinA nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injuryNonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.Enhanced anti-inflammatory potency of a nitric oxide-releasing prednisolone derivative in the rat.Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.Single injection of a sustained-release prostacyclin analog improves pulmonary hypertension in rats.Effect of aspartame on oxidative stress and monoamine neurotransmitter levels in lipopolysaccharide-treated mice.Nigrostriatal damage after systemic rotenone and/or lipopolysaccharide and the effect of cannabis
P2860
Q24685768-726B26A0-86D5-4B4A-9734-DF6A45848C33Q28166417-F0ED191A-9E97-426A-A334-D208205DA423Q28200449-543BA909-04E1-476F-A2B4-E72C393EF21BQ33631601-3686E7A0-2480-4F1C-AE72-1BE436DDF20EQ34376402-A3815C8D-72A1-4253-9582-A68D54A05BE1Q34557288-4A902D60-E7C7-45C3-B233-2BE0436331A9Q34574584-FB860F98-88D7-4527-BEE6-033DEE766DC5Q35046026-B4AF9BB3-0A29-4CA7-B9F0-4640E9AFBC88Q38558587-4AB633B1-7C61-4346-A04D-67A9A77E9E93Q42162863-59281689-3EB8-45F1-ACB7-A128C1BE7725Q42667008-1430DAA8-B579-4997-9728-025D7C6363C7Q46920621-ABE57FEE-828A-452F-A3AC-354FC1A32930Q48959520-864CD2FA-5AC8-4115-9D82-BF5E69F56060Q57729911-26011C87-04EA-4D00-8C42-C4C8FE470D44
P2860
NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
NCX-4016 (NO-aspirin) inhibits ...... in vivo: role of nitric oxide
@ast
NCX-4016 (NO-aspirin) inhibits ...... in vivo: role of nitric oxide
@en
NCX-4016 (NO-aspirin) inhibits ...... in vivo: role of nitric oxide
@nl
type
label
NCX-4016 (NO-aspirin) inhibits ...... in vivo: role of nitric oxide
@ast
NCX-4016 (NO-aspirin) inhibits ...... in vivo: role of nitric oxide
@en
NCX-4016 (NO-aspirin) inhibits ...... in vivo: role of nitric oxide
@nl
prefLabel
NCX-4016 (NO-aspirin) inhibits ...... in vivo: role of nitric oxide
@ast
NCX-4016 (NO-aspirin) inhibits ...... in vivo: role of nitric oxide
@en
NCX-4016 (NO-aspirin) inhibits ...... in vivo: role of nitric oxide
@nl
P2093
P1433
P1476
NCX-4016 (NO-aspirin) inhibits ...... in vivo: role of nitric oxide
@en
P2093
Alessandra Meneguzzi
Alessandro Lechi
Andrea Mencarelli
Antonio Morelli
Piero del Soldato
Pietro Minuz
P304
P356
10.1161/01.CIR.0000039341.57809.1E
P407
P577
2002-12-10T00:00:00Z